RISE CAB training package
>
Skip to content

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved 2016 2016
Generic versions of TDF/xTC* for prevention
Under Review
ViiV's Apretude (CAB for PrEP) Registration
Approved 2023 2023
IPM's Dapivirine Vaginal Ring Registration
Approved 2023 2023
Oral F/TAF (Descovy) Registration
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

1 Planned/Ongoing Projects

Featured Resources